John Patrick Shannon Jr.

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Morristown, NJ
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Beth Hecht, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for John Patrick Shannon Jr.

Form 4 holding Chief Executive Officer and Chairman of the Board, Director

Xeris Biopharma Holdings, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
639,639
Estimated value
Report date
30 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Executive Officer and Chairman of the Board, Director

Xeris Biopharma Holdings, Inc.

Security class
Stock Appreciation Right
Shares / value
600,000
Estimated value
Report date
31 Jan 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President and Chief Operating Officer

XERIS PHARMACEUTICALS INC

Security class
Common Stock
Shares / value
0
Estimated value
Report date
05 Oct 2021
Price
Ownership
Direct
Form 4 holding President and Chief Operating Officer

XERIS PHARMACEUTICALS INC

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
05 Oct 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by John Patrick Shannon Jr.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .